{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:21:21Z","timestamp":1788805281454,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370909"],"award-info":[{"award-number":["81370909"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010226"],"award-info":[{"award-number":["2020A1515010226"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"lacal innovative and reseach team project of Guangdong Pearl River Talents Program","award":["2017BT01S131"],"award-info":[{"award-number":["2017BT01S131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12020-020-02470-7","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T10:02:11Z","timestamp":1598781731000},"page":"517-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide"],"prefix":"10.1007","volume":"70","author":[{"given":"Yunzhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"issue":"1","key":"2470_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"H. Tilg, A.R. Moschen, M. Roden, NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 14(1), 32\u201342 (2017). https:\/\/doi.org\/10.1038\/nrgastro.2016.147","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"2470_CR2","doi-asserted-by":"publisher","first-page":"22933","DOI":"10.3390\/ijms141122933","volume":"14","author":"B Fruci","year":"2013","unstructured":"B. Fruci, S. Giuliano, A. Mazza, R. Malaguarnera, A. Belfiore, Nonalcoholic fatty liver: a possible new target for type 2 diabetes prevention and treatment. Int. J. Mol. Sci. 14(11), 22933\u201322966 (2013). https:\/\/doi.org\/10.3390\/ijms141122933","journal-title":"Int. J. Mol. Sci."},{"key":"2470_CR3","doi-asserted-by":"publisher","unstructured":"A.A. Alsabaani, A.A. Mahfouz, N.J. Awadalla, M.J. Musa, S.M. Al Humayed, Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia. Int. J. Environ. Res. Public Health 15(11), (2018). https:\/\/doi.org\/10.3390\/ijerph15112521","DOI":"10.3390\/ijerph15112521"},{"issue":"3","key":"2470_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"G. Targher, C.D. Byrne, A. Lonardo, G. Zoppini, C. Barbui, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J. Hepatol. 65(3), 589\u2013600 (2016). https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013","journal-title":"J. Hepatol."},{"issue":"2","key":"2470_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"E. Vilar-Gomez, Y. Martinez-Perez, L. Calzadilla-Bertot, A. Torres-Gonzalez, B. Gra-Oramas, L. Gonzalez-Fabian, S.L. Friedman, M. Diago, M. Romero-Gomez, Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149(2), 367\u2013378.e365 (2015). https:\/\/doi.org\/10.1053\/j.gastro.2015.04.005. quiz e314-365","journal-title":"Gastroenterology"},{"issue":"7","key":"2470_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","volume":"19","author":"P Farzanegi","year":"2019","unstructured":"P. Farzanegi, A. Dana, Z. Ebrahimpoor, M. Asadi, M.A. Azarbayjani, Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. Eur. J. Sport Sci. 19(7), 994\u20131003 (2019). https:\/\/doi.org\/10.1080\/17461391.2019.1571114","journal-title":"Eur. J. Sport Sci."},{"issue":"40","key":"2470_CR7","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.3748\/wjg.v20.i40.14821","volume":"20","author":"XC Wang","year":"2014","unstructured":"X.C. Wang, A.M. Gusdon, H. Liu, S. Qu, Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. World J. Gastroenterol. 20(40), 14821\u201314830 (2014). https:\/\/doi.org\/10.3748\/wjg.v20.i40.14821","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"2470_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s42000-018-0021-9","volume":"17","author":"L Iogna Prat","year":"2018","unstructured":"L. Iogna Prat, E.A. Tsochatzis, The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD). Hormones 17(2), 219\u2013229 (2018). https:\/\/doi.org\/10.1007\/s42000-018-0021-9","journal-title":"Hormones"},{"key":"2470_CR9","doi-asserted-by":"publisher","unstructured":"P. Pingitore, K. Sasidharan, M. Ekstrand, S. Prill, D. Lind\u00e9n, S. Romeo, Human multilineage 3D spheroids as a model of liver steatosis and fibrosis. Int. J. Mol. Sci. 20(7), (2019). https:\/\/doi.org\/10.3390\/ijms20071629","DOI":"10.3390\/ijms20071629"},{"issue":"12","key":"2470_CR10","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.2337\/db06-0558","volume":"55","author":"DL Williams","year":"2006","unstructured":"D.L. Williams, D.G. Baskin, M.W. Schwartz, Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 55(12), 3387\u20133393 (2006). https:\/\/doi.org\/10.2337\/db06-0558","journal-title":"Diabetes"},{"issue":"11","key":"2470_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4254\/wjh.v10.i11.790","volume":"10","author":"M Kalogirou","year":"2018","unstructured":"M. Kalogirou, E. Sinakos, Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? World J. Hepatol. 10(11), 790\u2013794 (2018). https:\/\/doi.org\/10.4254\/wjh.v10.i11.790","journal-title":"World J. Hepatol."},{"issue":"10019","key":"2470_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/s0140-6736(15)00803-x","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"M.J. Armstrong, P. Gaunt, G.P. Aithal, D. Barton, D. Hull, R. Parker, J.M. Hazlehurst, K. Guo, G. Abouda, M.A. Aldersley, D. Stocken, S.C. Gough, J.W. Tomlinson, R.M. Brown, S.G. H\u00fcbscher, P.N. Newsome, Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 387(10019), 679\u2013690 (2016). https:\/\/doi.org\/10.1016\/s0140-6736(15)00803-x","journal-title":"Lancet"},{"issue":"5","key":"2470_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00592-014-0638-3","volume":"51","author":"Y Bi","year":"2014","unstructured":"Y. Bi, B. Zhang, W. Xu, H. Yang, W. Feng, C. Li, G. Tong, M. Li, X. Wang, S. Shen, B. Zhu, J. Weng, D. Zhu, Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes. Acta Diabetol. 51(5), 865\u2013873 (2014). https:\/\/doi.org\/10.1007\/s00592-014-0638-3","journal-title":"Acta Diabetol."},{"issue":"6","key":"2470_CR14","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","volume":"57","author":"C Pirazzi","year":"2012","unstructured":"C. Pirazzi, M. Adiels, M.A. Burza, R.M. Mancina, M. Levin, M. Stahlman, M.R. Taskinen, M. Orho-Melander, J. Perman, A. Pujia, L. Andersson, C. Maglio, T. Montalcini, O. Wiklund, J. Boren, S. Romeo, Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57(6), 1276\u20131282 (2012). https:\/\/doi.org\/10.1016\/j.jhep.2012.07.030","journal-title":"J. Hepatol."},{"issue":"6","key":"2470_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"S. Sookoian, C.J. Pirola, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53(6), 1883\u20131894 (2011). https:\/\/doi.org\/10.1002\/hep.24283","journal-title":"Hepatology"},{"issue":"1","key":"2470_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","volume":"61","author":"YL Liu","year":"2014","unstructured":"Y.L. Liu, G.L. Patman, J.B. Leathart, A.C. Piguet, A.D. Burt, J.F. Dufour, C.P. Day, A.K. Daly, H.L. Reeves, Q.M. Anstee, Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J. Hepatol. 61(1), 75\u201381 (2014). https:\/\/doi.org\/10.1016\/j.jhep.2014.02.030","journal-title":"J. Hepatol."},{"issue":"1","key":"2470_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.27242","volume":"61","author":"E Smagris","year":"2015","unstructured":"E. Smagris, S. BasuRay, J. Li, Y. Huang, K.M. Lai, J. Gromada, J.C. Cohen, H.H. Hobbs, Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61(1), 108\u2013118 (2015). https:\/\/doi.org\/10.1002\/hep.27242","journal-title":"Hepatology"},{"key":"2470_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","volume":"22","author":"D Lind\u00e9n","year":"2019","unstructured":"D. Lind\u00e9n, A. Ahnmark, P. Pingitore, E. Ciociola, I. Ahlstedt, A.C. Andr\u00e9asson, K. Sasidharan, K. Madeyski-Bengtson, M. Zurek, R.M. Mancina, A. Lindblom, M. Bjursell, G. B\u00f6ttcher, M. St\u00e5hlman, Y.M. Bohlooly, W.G. Haynes, B. Carlsson, M. Graham, R. Lee, S. Murray, L. Valenti, S. Bhanot, P. \u00c5kerblad, S. Romeo, Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. Mol. Metab. 22, 49\u201361 (2019). https:\/\/doi.org\/10.1016\/j.molmet.2019.01.013","journal-title":"Mol. Metab."},{"issue":"Suppl 5","key":"2470_CR19","doi-asserted-by":"publisher","first-page":"S627","DOI":"10.33549\/physiolres.933224","volume":"64","author":"A Moravcov\u00e1","year":"2015","unstructured":"A. Moravcov\u00e1, Z. \u010cervinkov\u00e1, O. Ku\u010dera, V. Mezera, D. Rychtrmoc, H. Lotkov\u00e1, The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture. Physiol. Res. 64(Suppl 5), S627\u2013S636 (2015). https:\/\/doi.org\/10.33549\/physiolres.933224","journal-title":"Physiol. Res."},{"issue":"1","key":"2470_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/joim.12293","volume":"277","author":"W Xu","year":"2015","unstructured":"W. Xu, Y. Bi, Z. Sun, J. Li, L. Guo, T. Yang, G. Wu, L. Shi, Z. Feng, L. Qiu, Q. Li, X. Guo, Z. Luo, J. Lu, Z. Shan, W. Yang, Q. Ji, L. Yan, H. Li, X. Yu, S. Li, Z. Zhou, X. Lv, Z. Liang, S. Lin, L. Zeng, J. Yan, L. Ji, J. Weng, Comparison of the effects on glycaemic control and beta-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study). J. Intern. Med. 277(1), 137\u2013150 (2015). https:\/\/doi.org\/10.1111\/joim.12293","journal-title":"J. Intern. Med."},{"issue":"5","key":"2470_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/apt.13521","volume":"43","author":"MF Xia","year":"2016","unstructured":"M.F. Xia, Y. Ling, H. Bian, H.D. Lin, H.M. Yan, X.X. Chang, X.M. Li, H. Ma, D. Wang, L.S. Zhang, S.S. Wang, B.J. Wu, W.Y. He, N.Q. Zhao, X. Gao, I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. Aliment. Pharmacol. Ther. 43(5), 631\u2013642 (2016). https:\/\/doi.org\/10.1111\/apt.13521","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2470_CR22","doi-asserted-by":"publisher","unstructured":"G. Aragones, T. Auguet, S. Armengol, A. Berlanga, E. Guiu-Jurado, C. Aguilar, S. Martinez, F. Sabench, J.A. Porras, M.D. Ruiz, M. Hernandez, J.J. Sirvent, D. Del Castillo, C. Richart, PNPLA3 expression is related to liver steatosis in morbidly obese women with non-alcoholic fatty liver disease. Int. J. Mol. Sci. 17(5) (2016). https:\/\/doi.org\/10.3390\/ijms17050630","DOI":"10.3390\/ijms17050630"},{"issue":"11","key":"2470_CR23","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1172\/jci65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"J.Z. Li, Y. Huang, R. Karaman, P.T. Ivanova, H.A. Brown, T. Roddy, J. Castro-Perez, J.C. Cohen, H.H. Hobbs, Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 122(11), 4130\u20134144 (2012). https:\/\/doi.org\/10.1172\/jci65179","journal-title":"J. Clin. Invest."},{"issue":"3","key":"2470_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/hep.23812","volume":"52","author":"W Chen","year":"2010","unstructured":"W. Chen, B. Chang, L. Li, L. Chan, Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52(3), 1134\u20131142 (2010). https:\/\/doi.org\/10.1002\/hep.23812","journal-title":"Hepatology"},{"issue":"4","key":"2470_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.11909\/j.issn.1671-5411.2015.04.013","volume":"12","author":"YG Wang","year":"2015","unstructured":"Y.G. Wang, T.L. Yang, Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK\/SREBP1 pathway. J. Geriatr. Cardiol. 12(4), 410\u2013416 (2015). https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2015.04.013","journal-title":"J. Geriatr. Cardiol."},{"issue":"2","key":"2470_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3803\/EnM.2015.30.2.177","volume":"30","author":"J Lee","year":"2015","unstructured":"J. Lee, S.W. Hong, S.E. Park, E.J. Rhee, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Exendin-4 inhibits the expression of SEPP1 and Fetuin-A via improvement of palmitic acid-induced endoplasmic reticulum stress by AMPK. Endocrinol. Metab. 30(2), 177\u2013184 (2015). https:\/\/doi.org\/10.3803\/EnM.2015.30.2.177","journal-title":"Endocrinol. Metab."},{"key":"2470_CR27","doi-asserted-by":"publisher","unstructured":"S. Sharma, J.E. Mells, P.P. Fu, N.K. Saxena, F.A. Anania, GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS ONE 6(9), (2011). https:\/\/doi.org\/10.1371\/journal.pone.0025269","DOI":"10.1371\/journal.pone.0025269"},{"issue":"47","key":"2470_CR28","doi-asserted-by":"publisher","first-page":"48968","DOI":"10.1074\/jbc.M407841200","volume":"279","author":"CM Jenkins","year":"2004","unstructured":"C.M. Jenkins, D.J. Mancuso, W. Yan, H.F. Sims, B. Gibson, R.W. Gross, Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 279(47), 48968\u201348975 (2004). https:\/\/doi.org\/10.1074\/jbc.M407841200","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2470_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","volume":"31","author":"S Romeo","year":"2020","unstructured":"S. Romeo, A. Sanyal, L. Valenti, Leveraging human genetics to identify potential new treatments for fatty liver disease. Cell Metab. 31(1), 35\u201345 (2020). https:\/\/doi.org\/10.1016\/j.cmet.2019.12.002","journal-title":"Cell Metab."},{"issue":"5","key":"2470_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","volume":"15","author":"M Kumari","year":"2012","unstructured":"M. Kumari, G. Schoiswohl, C. Chitraju, M. Paar, I. Cornaciu, A.Y. Rangrez, N. Wongsiriroj, H.M. Nagy, P.T. Ivanova, S.A. Scott, O. Knittelfelder, G.N. Rechberger, R. Birner-Gruenberger, S. Eder, H.A. Brown, G. Haemmerle, M. Oberer, A. Lass, E.E. Kershaw, R. Zimmermann, R. Zechner, Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab. 15(5), 691\u2013702 (2012). https:\/\/doi.org\/10.1016\/j.cmet.2012.04.008","journal-title":"Cell Metab."},{"issue":"2","key":"2470_CR31","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/jcmm.14839","volume":"24","author":"S Yuan","year":"2020","unstructured":"S. Yuan, H. Liu, D. Yuan, J. Xu, Y. Chen, X. Xu, F. Xu, H. Liang, PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells. J. Cell. Mole. Med. 24(2), 1541\u20131552 (2020). https:\/\/doi.org\/10.1111\/jcmm.14839","journal-title":"J. Cell. Mole. Med."},{"issue":"6","key":"2470_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/hep.29041","volume":"65","author":"FV Bruschi","year":"2017","unstructured":"F.V. Bruschi, T. Claudel, M. Tardelli, A. Caligiuri, T.M. Stulnig, F. Marra, M. Trauner, The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology 65(6), 1875\u20131890 (2017). https:\/\/doi.org\/10.1002\/hep.29041","journal-title":"Hepatology"},{"issue":"9","key":"2470_CR33","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/jcp.24951","volume":"230","author":"H Liang","year":"2015","unstructured":"H. Liang, J. Xu, F. Xu, H. Liu, D. Yuan, S. Yuan, M. Cai, J. Yan, J. Weng, The SRE Motif in the human PNPLA3 promoter (-97 to -88 bp) mediates transactivational effects of SREBP-1c. J. Cell. Physiol. 230(9), 2224\u20132232 (2015). https:\/\/doi.org\/10.1002\/jcp.24951","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"2470_CR34","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.2337\/db14-0263","volume":"63","author":"F Xu","year":"2014","unstructured":"F. Xu, Z. Li, X. Zheng, H. Liu, H. Liang, H. Xu, Z. Chen, K. Zeng, J. Weng, SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Diabetes 63(11), 3637\u20133646 (2014). https:\/\/doi.org\/10.2337\/db14-0263","journal-title":"Diabetes"},{"key":"2470_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.mce.2017.09.012","volume":"461","author":"S Suzuki","year":"2018","unstructured":"S. Suzuki, J.R. Iben, S.L. Coon, T. Kino, SIRT1 is a transcriptional enhancer of the glucocorticoid receptor acting independently to its deacetylase activity. Mol. Cell. Endocrinol. 461, 178\u2013187 (2018). https:\/\/doi.org\/10.1016\/j.mce.2017.09.012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"2470_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.gastro.2013.10.059","volume":"146","author":"Y Li","year":"2014","unstructured":"Y. Li, K. Wong, A. Giles, J. Jiang, J.W. Lee, A.C. Adams, A. Kharitonenkov, Q. Yang, B. Gao, L. Guarente, M. Zang, Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology 146(2), 539\u2013549.e537 (2014). https:\/\/doi.org\/10.1053\/j.gastro.2013.10.059","journal-title":"Gastroenterology"},{"issue":"6","key":"2470_CR37","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1210\/jc.2003-031978","volume":"89","author":"YM Liu","year":"2004","unstructured":"Y.M. Liu, M. Moldes, J.P. Bastard, E. Bruckert, N. Viguerie, B. Hainque, A. Basdevant, D. Langin, J. Pairault, K. Clement, Adiponutrin: a new gene regulated by energy balance in human adipose tissue. J. Clin. Endocrinol. Metab. 89(6), 2684\u20132689 (2004). https:\/\/doi.org\/10.1210\/jc.2003-031978","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02470-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T23:53:38Z","timestamp":1630281218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02470-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2470"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02470-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,30]]},"assertion":[{"value":"16 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}